240 related articles for article (PubMed ID: 32581291)
1. Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation.
Okarmus J; Bogetofte H; Schmidt SI; Ryding M; García-López S; Ryan BJ; Martínez-Serrano A; Hyttel P; Meyer M
Sci Rep; 2020 Jun; 10(1):10278. PubMed ID: 32581291
[TBL] [Abstract][Full Text] [Related]
2. USP30 inhibition induces mitophagy and reduces oxidative stress in parkin-deficient human neurons.
Okarmus J; Agergaard JB; Stummann TC; Haukedal H; Ambjørn M; Freude KK; Fog K; Meyer M
Cell Death Dis; 2024 Jan; 15(1):52. PubMed ID: 38225227
[TBL] [Abstract][Full Text] [Related]
3. Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism.
Okarmus J; Havelund JF; Ryding M; Schmidt SI; Bogetofte H; Heon-Roberts R; Wade-Martins R; Cowley SA; Ryan BJ; Færgeman NJ; Hyttel P; Meyer M
Stem Cell Reports; 2021 Jun; 16(6):1510-1526. PubMed ID: 34048689
[TBL] [Abstract][Full Text] [Related]
4. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function.
Hwang CJ; Kim YE; Son DJ; Park MH; Choi DY; Park PH; Hellström M; Han SB; Oh KW; Park EK; Hong JT
Redox Biol; 2017 Apr; 11():456-468. PubMed ID: 28086194
[TBL] [Abstract][Full Text] [Related]
5. Generation of three induced pluripotent stem cell lines from a Parkinson's disease patient with mutant PARKIN (p. C253Y).
Tariq M; Liu H; Ibañez DP; Li Y; Chen S; Jiang M; Fan W; Zhao P; Luo Z; Wang D; Kanwal S
Stem Cell Res; 2020 May; 45():101822. PubMed ID: 32387897
[TBL] [Abstract][Full Text] [Related]
6. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
Pinto M; Nissanka N; Moraes CT
J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
[No Abstract] [Full Text] [Related]
7. The endoplasmic reticulum-mitochondria interface is perturbed in PARK2 knockout mice and patients with PARK2 mutations.
Gautier CA; Erpapazoglou Z; Mouton-Liger F; Muriel MP; Cormier F; Bigou S; Duffaure S; Girard M; Foret B; Iannielli A; Broccoli V; Dalle C; Bohl D; Michel PP; Corvol JC; Brice A; Corti O
Hum Mol Genet; 2016 Jul; 25(14):2972-2984. PubMed ID: 27206984
[TBL] [Abstract][Full Text] [Related]
8. Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutation.
Bogetofte H; Jensen P; Okarmus J; Schmidt SI; Agger M; Ryding M; Nørregaard P; Fenger C; Zeng X; Graakjær J; Ryan BJ; Wade-Martins R; Larsen MR; Meyer M
Neurobiol Dis; 2019 Dec; 132():104581. PubMed ID: 31445161
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Quality Control via the PGC1α-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin.
Siddiqui A; Bhaumik D; Chinta SJ; Rane A; Rajagopalan S; Lieu CA; Lithgow GJ; Andersen JK
J Neurosci; 2015 Sep; 35(37):12833-44. PubMed ID: 26377470
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines.
Shaltouki A; Sivapatham R; Pei Y; Gerencser AA; Momčilović O; Rao MS; Zeng X
Stem Cell Reports; 2015 May; 4(5):847-59. PubMed ID: 25843045
[TBL] [Abstract][Full Text] [Related]
11. Parkin Modulates Endosomal Organization and Function of the Endo-Lysosomal Pathway.
Song P; Trajkovic K; Tsunemi T; Krainc D
J Neurosci; 2016 Feb; 36(8):2425-37. PubMed ID: 26911690
[TBL] [Abstract][Full Text] [Related]
12. Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice.
Noda S; Sato S; Fukuda T; Tada N; Uchiyama Y; Tanaka K; Hattori N
Neurobiol Dis; 2020 Mar; 136():104717. PubMed ID: 31846738
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease.
Dave KD; De Silva S; Sheth NP; Ramboz S; Beck MJ; Quang C; Switzer RC; Ahmad SO; Sunkin SM; Walker D; Cui X; Fisher DA; McCoy AM; Gamber K; Ding X; Goldberg MS; Benkovic SA; Haupt M; Baptista MA; Fiske BK; Sherer TB; Frasier MA
Neurobiol Dis; 2014 Oct; 70():190-203. PubMed ID: 24969022
[TBL] [Abstract][Full Text] [Related]
14. Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.
Pickrell AM; Huang CH; Kennedy SR; Ordureau A; Sideris DP; Hoekstra JG; Harper JW; Youle RJ
Neuron; 2015 Jul; 87(2):371-81. PubMed ID: 26182419
[TBL] [Abstract][Full Text] [Related]
15. Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson's disease with PARK2 mutation.
Ishikawa KI; Okuzumi A; Yoshino H; Hattori N; Akamatsu W
Stem Cell Res; 2024 Apr; 76():103323. PubMed ID: 38309147
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Parkin in the Neuronal Progenitor Cells from a Patient with Parkinson's Disease Shifts the Transcriptome Towards the Normal State.
Lebedeva O; Poberezhniy D; Novosadova E; Gerasimova T; Novosadova L; Arsenyeva E; Stepanenko E; Shimchenko D; Volovikov E; Anufrieva K; Illarioshkin S; Lagarkova M; Grivennikov I; Tarantul V; Nenasheva V
Mol Neurobiol; 2023 Jun; 60(6):3522-3533. PubMed ID: 36884134
[TBL] [Abstract][Full Text] [Related]
17. Parkin absence accelerates microtubule aging in dopaminergic neurons.
Cartelli D; Amadeo A; Calogero AM; Casagrande FVM; De Gregorio C; Gioria M; Kuzumaki N; Costa I; Sassone J; Ciammola A; Hattori N; Okano H; Goldwurm S; Roybon L; Pezzoli G; Cappelletti G
Neurobiol Aging; 2018 Jan; 61():66-74. PubMed ID: 29040870
[TBL] [Abstract][Full Text] [Related]
18. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
[TBL] [Abstract][Full Text] [Related]
19. SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila.
Zanon A; Kalvakuri S; Rakovic A; Foco L; Guida M; Schwienbacher C; Serafin A; Rudolph F; Trilck M; Grünewald A; Stanslowsky N; Wegner F; Giorgio V; Lavdas AA; Bodmer R; Pramstaller PP; Klein C; Hicks AA; Pichler I; Seibler P
Hum Mol Genet; 2017 Jul; 26(13):2412-2425. PubMed ID: 28379402
[TBL] [Abstract][Full Text] [Related]
20. Parkin Knockout Inhibits Neuronal Development via Regulation of Proteasomal Degradation of p21.
Park MH; Lee HJ; Lee HL; Son DJ; Ju JH; Hyun BK; Jung SH; Song JK; Lee DH; Hwang CJ; Han SB; Kim S; Hong JT
Theranostics; 2017; 7(7):2033-2045. PubMed ID: 28656059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
